- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01849315
Effects of Physical Activity on Disease Risk Factors
May 6, 2013 updated by: Cheryl Howe, Ohio University
Effects of an Empirically-Based Physical Activity Intervention on Chronic Disease Risk Factors in Children
Obesity is associated with increased risk of heart disease and diabetes (Kim et al., 2010).
Appalachian children in Athens County, Ohio, experience higher rates of obesity compared to the national average (20.9% vs. 15.4%), which increases their risk of obesity-related diseases (Montgomery-Reagan, Bianco, Heh, Rettos, & Huston, 2009).
Although physical activity (PA) is known to improve fitness and adiposity (Gutin & Owens, 2011; Yin et al., 2009), very little is known about the effects of PA on the progression of chronic disease risk factors (biomarkers) for obesity-related diseases in children, such as inflammatory markers, lipids, and glucose/insulin.
This lack of knowledge is due to a limited understanding of the number of calories burned during children's free-play PA.
This study will assess the impact of a PA program (ACT) of known energy cost on obesity-related disease markers in 2nd-4th grade children compared to a sedentary control group (SED).
The study will recruit children from an after-school program in Athens County elementary schools.
Baseline and posttest data will include measures of height, weight, body composition, blood pressure, and physical activity levels.
Following baseline measures, children will be randomized into either the ACT or SED group for 8 weeks.
The ACT group will play recess-type games previously determined to expend ≥100 calories in 30 minutes.
The SED group children will play sedentary-type activities during the same time period.
It is hypothesized that the ACT group children will demonstrate significant improvements in PA after 8 weeks compared to the SED group children and that these improvements will be related to positive changes in body weight and body composition.
Study Overview
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 12 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Attends participating after school program
Exclusion Criteria:
- cardiorespiratory, metabolic, and neurological disorders and physical impairments that would prevent them from being physically active, and were not taking any medications that would affect metabolism
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control
Sedentary intervention
|
Physically active intervention
|
|
Active Comparator: AKIDS II
Physically active group
|
Physically active intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Daily Physical Activity Levels
Time Frame: 8 weeks
|
increase relative to participation in intervention
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
body composition
Time Frame: 8 weeks
|
attenuation in excess gains in weight and body mass index
|
8 weeks
|
|
biomarkers for cardiometabolic disease
Time Frame: 8 weeks
|
decrease relative to intervention participation
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2012
Primary Completion (Actual)
March 1, 2013
Study Completion (Actual)
March 1, 2013
Study Registration Dates
First Submitted
May 6, 2013
First Submitted That Met QC Criteria
May 6, 2013
First Posted (Estimate)
May 8, 2013
Study Record Updates
Last Update Posted (Estimate)
May 8, 2013
Last Update Submitted That Met QC Criteria
May 6, 2013
Last Verified
May 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12F011
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.